CRIS Curis Inc.

2.01
+0.05  (+3%)
Previous Close 1.96
Open 1.96
Price To Book -3.3
Market Cap 66,737,771
Shares 33,202,871
Volume 139,464
Short Ratio
Av. Daily Volume 214,853

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 interim data released August 6, 2019. Further update due later in 2019.
CA-4948
Relapsed or Refractory Non-Hodgkin Lymphoma
Phase 1 mesothelioma data due 2H 2019.
CA170
Solid Tumors and Lymphomas
Approved January 30, 2012.
Vismodegib
Basal Cell Carcinoma
Phase 1b initial data in DH/DE DLBCL 2H 2019.
Fimepinostat (CUDC-907) and venetoclax
Diffuse-large B-cell lymphoma (DLBCL)